• +1-646-491-9876
    • +91-20-67278686

    Search

    Male Infertility - Pipeline Review, H1 2017

    Male Infertility - Pipeline Review, H1 2017

    • Report Code ID: RW0001709427
    • Category Pharmaceuticals
    • No. of Pages 38
    • Publication Month Mar-17
    • Publisher Name Global Markets Direct
    Male Infertility - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Male Infertility - Pipeline Review, H1 2017, provides an overview of the Male Infertility (Male Health) pipeline landscape.

    Male infertility refers to a male's inability to achieve a pregnancy in a fertile female. Male infertility is caused due to low sperm production, immobile sperm, or blockages that prevent the delivery of sperm. Symptoms include pain, swelling or a lump in the testicle area. Predisposing factors include smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes surgery and hormone replacement therapy.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Male Infertility - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Male Infertility (Male Health) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Male Infertility (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 5, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

    Male Infertility (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Male Infertility (Male Health) .
    - The pipeline guide reviews pipeline therapeutics for Male Infertility (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Male Infertility (Male Health) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Male Infertility (Male Health) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Male Infertility (Male Health)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Male Infertility (Male Health) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Male Infertility (Male Health) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Male Infertility - Overview
    Male Infertility - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Male Infertility - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Male Infertility - Companies Involved in Therapeutics Development
    AlphaMab Co Ltd
    Ferring International Center SA
    Health Ever Bio-Tech Co Ltd
    Navya Biologicals Pvt Ltd
    PharmaEssentia Corp
    TocopheRx Inc
    Zydus Cadila Healthcare Ltd
    Male Infertility - Drug Profiles
    Biosimilar 2 for Diabetes, Infertility and Rheumatoid Arthritis - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Biosimilar 5 for Infertility and Oncology - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Biosimilar 6 for Infertility, Oncology and Immunology - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Biosimilar 7 for Infertility, Immunology, Infectious Disease and Oncology - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    FE-999310 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    LM-002 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    MCS-5 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    NAV-013 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    PEG-FSH - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Recombinant Beta Glucosidase 2 Replacement for Gaucher's Disease and Male Infertility - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    TOP-001 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    TOP-002 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    trequinsin - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Male Infertility - Dormant Projects
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Male Infertility, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Male Infertility - Pipeline by AlphaMab Co Ltd, H1 2017
    Male Infertility - Pipeline by Ferring International Center SA, H1 2017
    Male Infertility - Pipeline by Health Ever Bio-Tech Co Ltd, H1 2017
    Male Infertility - Pipeline by Navya Biologicals Pvt Ltd, H1 2017
    Male Infertility - Pipeline by PharmaEssentia Corp, H1 2017
    Male Infertility - Pipeline by TocopheRx Inc, H1 2017
    Male Infertility - Pipeline by Zydus Cadila Healthcare Ltd, H1 2017
    Male Infertility - Dormant Projects, H1 2017

    List of Figures

    Number of Products under Development for Male Infertility, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Targets, H1 2017
    Number of Products by Stage and Targets, H1 2017
    Number of Products by Mechanism of Actions, H1 2017
    Number of Products by Stage and Mechanism of Actions, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    AlphaMab Co Ltd
    Ferring International Center SA
    Health Ever Bio-Tech Co Ltd
    Navya Biologicals Pvt Ltd
    PharmaEssentia Corp
    TocopheRx Inc
    Zydus Cadila Healthcare Ltd

    Request for Sample

    Report Url http://www.reportsweb.com//male-infertility-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//male-infertility-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//male-infertility-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments